Influenza nucleic acid molecules and vaccines made therefrom
US-9192660-B2 · Nov 24, 2015 · US
US10934552B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10934552-B2 |
| Application number | US-201916503699-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 5, 2019 |
| Priority date | Mar 14, 2019 |
| Publication date | Mar 2, 2021 |
| Grant date | Mar 2, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure herein relates to construction and application of engineering bacteria capable of secreting and expressing diacetylchitobiose deacetylase, and belongs to the technical field of fermentation engineering. Firstly, recombinant B. subtilis capable of heterologously secreting and expressing a diacetylchitobiose deacetylase gene is constructed, and a signal peptide fragment yncM is added into the recombinant vector for the first time. The signal peptide can secrete the target protein diacetylchitobiose deacetylase outside the cells of the recombinant B. subtilis, and a mutant of the 5′-end untranslated region is acquired, thereby significantly increasing the expression level of the target protein, and greatly simplifying the subsequent enzyme separation and purification steps. When the acquired diacetylchitobiose deacetylase is fermented and cultured in a fermentation medium for 50-60 h, the enzyme activity reaches a maximum of 1,548.7 U/mL, and the maximum yield of the diacetylchitobiose deacetylase is about 620 mg/L. Simultaneously, the method has the advantages of low production cost, mild production conditions, simple purification process steps, safe production operation and the like.
Opening claim text (preview).
What is claimed is: 1. A genetically engineered bacterium, comprising an expression vector encoding a diacetylchitobiose deacetylase gene fused downstream to a yncM signal peptide, wherein the diacetylchitobiose deacetylase gene harbors a DNA fragment comprising SEQ ID NO:3 in a 5′-untranslated region of the diacetylchitobiose deacetylase gene. 2. The bacterium according to claim 1 , wherein the diacetylchitobiose deacetylase GenBank accession number is PH0499. 3. The bacterium according to claim 1 , wherein an amino acid sequence of the yncM signal peptide is SEQ ID NO:5. 4. The bacterium according to claim 3 , wherein a nucleotide sequence that encodes the yncM signal peptide is SEQ ID NO:1. 5. The bacterium according to claim 1 , wherein the expression vector is p43NMK. 6. The bacterium according to claim 1 , wherein the bacterium is B. subtilis. 7. The bacterium according to claim 6 , wherein the B. subtilis is strain WB600. 8. A method of producing diacetylchitobiose deacetylase, comprising: inserting into a host bacterium an expression vector encoding a diacetylchitobiose deacetylase gene fused downstream to a yncM signal peptide, wherein the diacetylchitobiose deacetylase gene harbors a DNA fragment comprising SEQ ID NO:3 in a 5′-untranslated region of the diacetylchitobiose deacetylase gene, inoculating a fermentation culture with the bacterium, incubating the culture under conditions that favor expression of the diacetylchitobiose deacetylase, and obtaining diacetylchitobiose deacetylase from the culture. 9. The method according to claim 8 , wherein inoculating the bacterium into the fermentation culture comprises inoculating a concentration of 2-5% of the bacterium into the culture, and wherein incubating is performed under conditions of 35 to 37° C. and shaking at 200 to 220 rpm for 14 to 96 hours. 10. The method according to claim 8 , wherein wherein incubating is performed under conditions of 35 to 37° C. and shaking at 200 to 220 rpm for 10 to 15 hours. 11. The method according to claim 8 , wherein the fermentation culture per liter comprises: 12 grams of peptone, 24 grams of yeast powder, 10 grams NaCl, 4 mL glycerol, 2.31 grams KH 2 PO 4 and 12.54 grams K 2 HPO 4 . 12. The method according to claim 8 , wherein the fermentation culture per liter comprises: 10 grams peptone, 5 grams yeast powder, and 10 grams NaCl. 13. A method of preparing glucosamine, comprising: providing a genetically engineered bacterium comprising an expression vector encoding a diacetylchitobiose deacetylase gene downstream of a yncM signal peptide, and harboring a DNA fragment comprising SEQ ID NO:3 in a 5′-untranslated region of the diacetylchitobiose deacetylase gene, inoculating a fermentation culture with the bacterium, and incubating the culture under conditions sufficient to express diacetylchitobiose deacetylase, thereby producing diacetylchitobiose deacetylase, and incubating the diacetylchitobiose deacetylase with acetylglucosamine to produce glucosamine. 14. The method according to claim 13 , which further comprises adding the glucosamine to a composition comprising a drug. 15. The method according to claim 13 , which further comprises adding the glucosamine to a dietary supplement.
acting on amide bonds in linear amides {(3.5.1)} · CPC title
Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine · CPC title
containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin (products from apiculture A23L21/20; artificial sweetening agents A23L27/30) · CPC title
for Bacillus · CPC title
Preparation of nitrogen-containing carbohydrates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.